Los Angeles – October 16, 2026 -- TORL BioTherapeutics has appointed Sandip Kapadia as Chief Financial Officer, a executive who has raised more than $2 billion in public capital for emerging biotechnology companies, and Eric Sievers, M.D., as Chief Medical Officer, completing a year-long expansion of its leadership team.

Las Vegas – October 16, 2026 -- Rareview Capital LLC and Tuttle Capital Management have launched the Tuttle - Rareview Humanoid Robotics ETF (HOID), an actively managed fund that targets both humanoid robot developers and the technologies inside them.

HOUSTON – October 16, 2026 -- MSC Income Fund, Inc. (NYSE: MSIF) will release its third quarter 2026 results on Thursday, November 5, 2026, after the financial markets close, the Houston-based fund said on October 16.

MSC Income Fund schedules Q3 call for November 6 at 11:00 a.m. Eastern

Management will hold a conference call on Friday, November 6, 2026, at 11:00 a.m. Eastern time, the morning after the release. The call will be broadcast live by phone and over the Internet, and investors can join by phone or audio webcast.

Berlin – October 16, 2026 -- Aignostics has launched HETA Clinical, a family of pan-cancer AI products aimed at the 10% to 20% of molecular tests that pathologists estimate fail because tissue contains too little tumor.

The first four products analyze whole slide H&E images across the pathology workflow, from intake and evaluation through to molecular testing. The company says the suite helps labs prioritize cases, cut turnaround time and confirm sufficient tumor content before molecular testing begins.

ORLANDO – October 16, 2026 -- Jeremiah's Italian Ice moved up four spots to No. 375 on the 2026 Franchise Times Top 400, up from No. 379 in 2025, in the annual ranking of the largest U.S.-based franchise systems by global systemwide sales.

The Franchise Times list is the result of a five-month research and reporting process covering franchise brands across industries.

New York – October 16, 2026 -- Mubadala Capital has completed its acquisition of Clear Channel Outdoor Holdings, a transaction valued at approximately $6.2 billion, after receiving all applicable regulatory approvals and the approval of Clear Channel stockholders.

Boston – October 16, 2026 -- Perceptive Discovery has become the first US provider able to run astatine-211 (At-211) radiopharmaceutical development studies, now available at its US and UK sites through a collaboration with Atley Solutions.

First Atley C100 module purifies At-211 at QMUL laboratory in London

At Perceptive Discovery's laboratory at Queen Mary University of London (QMUL), the first Atley C100 module in the collaboration is installed. It has been used to purify At-211 from an irradiated bismuth-209 target.

Columbus, Ohio – October 16, 2026 -- Core Molding Technologies (NYSE American: CMT) will take part in the 38th Annual Roth Conference on March 23-24, 2026, with management hosting one-on-one investor meetings at The Ritz-Carlton Laguna Niguel in Dana Point, California.

Core Molding opens two days of one-on-one investor access in Dana Point

The molder of structural products will meet investors individually rather than present in a public forum, according to the announcement. Investors seeking a slot can request a meeting through Roth at oneonone@roth.com.

Columbus, Ohio – October 16, 2026 -- Core Molding Technologies (NYSE American: CMT) has authorized a stock repurchase program of up to $7.5 million of its issued and outstanding common stock, which has a par value of $1.00 per share.

Board approval sets a $7.5 million ceiling on repurchases

The Board of Directors approved the program. Shares will be bought in the open market in accordance with applicable securities laws.

Columbus – October 16, 2026 -- Core Molding Technologies (NYSE American: CMT) will present to investors on June 10 from 3:20 to 3:55 PM ET at the 16th Annual East Coast IDEAS Investor Conference at The Westin New York at Times Square.

CEO Palomaki and CFO Panda represent Core Molding at the New York event

Chief Executive Officer Eric Palomaki and Chief Financial Officer Alex Panda will attend on the company's behalf. Core Molding will also hold one-on-one investor meetings throughout the conference day.